Search

Search Constraints

You searched for: Author/Creator Puliyanda, Dechu

Search Results

1. A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients. Issue 2 (February 2015)

2. A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients. Issue 11 (November 2015)

3. A phase I/II, double‐blind, placebo‐controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients. Issue 12 (14th May 2018)

4. Clinical and histopathologic features of antibody‐mediated rejection among pediatric renal transplant recipients with preformed vs de novo donor‐specific antibodies. (20th November 2017)

6. Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients. Issue 8 (12th June 2022)

7. Risk factors for the development of antibody‐mediated rejection in highly sensitized pediatric kidney transplant recipients. (19th September 2017)